The role of phosphatidylinositol 3-kinase, rho family GTPases, and STAT3 in Ros-induced cell transformation.
Using loss-of-function mutants of Ros and inducible epidermal growth factor receptor-Ros chimeras we investigated the role of various signaling pathways in Ros-induced cell transformation. Inhibition of the mitogen-activated protein kinase (MAPK) pathway with the MEK (MAP/extracellular signal-regulated kinase kinase) inhibitor PD98059 had little effect on the Ros-induced monolayer and anchorage-independent growth of chicken embryo fibroblasts and NIH3T3 cells even though more than 70% of the MAPK was inhibited. In contrast, inhibiting the phosphatidylinositol 3-kinase (PI3K) pathway with the drug LY294002, a dominant negative mutant of PI3K, Deltap85, or the phosphatidylinositol phosphatase PTEN (phosphatase and tensin homologue deleted in chromosome ten) resulted in a dramatic reduction of v-Ros- and epidermal growth factor receptor-Ros-promoted anchorage-independent growth of chicken embryo fibroblasts and NIH3T3 cells, respectively. Parallel and downstream components of PI3K signaling such as the Rho family GTPases (Rac, Rho, Cdc42) and the survival factor Akt were all shown to contribute to Ros-induced anchorage-independent growth, although Rac appeared to be less important for Ros-induced colony formation in NIH3T3 cells. Furthermore, the transformation-attenuated v-Ros mutants F419 and DI could be complemented by constitutively active mutants of PI3K and Akt. Finally, we found that overexpressing a constitutively active mutant of STAT3 (STAT3C) conferred a resistance to the inhibition of Ros-induced anchorage-independent growth by LY294002, suggesting a possible overlap of functions between PI3K and STAT3 signaling in mediating Ros-induced anchorage-independent growth.
Nguyen
Kevin T
KT
Department of Microbiology, Mount Sinai School of Medicine, New York, New York 10029, USA.
Zong
Cong S
CS
Uttamsingh
Shailaja
S
Sachdev
Pallavi
P
Bhanot
Monica
M
Le
Mai-Thao
MT
Chan
Joseph L-K
JL
Wang
Lu-Hai
LH
D000818:Animals; D002448:Cell Adhesion; D002455:Cell Division; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D002642:Chick Embryo; D002867:Chromones / Q000494:pharmacology; D004268:DNA-Binding Proteins / Q000502:physiology*; D005347:Fibroblasts; D005419:Flavonoids / Q000494:pharmacology; D020558:GTP Phosphohydrolases / Q000502:physiology*; D005799:Genes, Dominant; D020935:MAP Kinase Signaling System; D051379:Mice; D009025:Morpholines / Q000494:pharmacology; D009154:Mutation; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics / Q000502:physiology*; D012097:Repressor Proteins / Q000502:physiology*; D050796:STAT3 Transcription Factor; D020123:Sirolimus / Q000494:pharmacology; D015534:Trans-Activators / Q000502:physiology*
D002867:Chromones; D004268:DNA-Binding Proteins; D005419:Flavonoids; D009025:Morpholines; D012097:Repressor Proteins; D050796:STAT3 Transcription Factor; C494087:Stat3 protein, mouse; D015534:Trans-Activators; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; D019869:Phosphatidylinositol 3-Kinases; D020558:GTP Phosphohydrolases; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one; D020123:Sirolimus